ARCH Venture Fund XIII, L.P., Ten Percent Owner at Lyell Immunopharma, holds 3.25M shares in Lyell Immunopharma (Ticker: LYEL). Most recently, ARCH Venture Fund XIII, L.P. Bought 488,090 shares of Lyell Immunopharma on Mar 09, 2026 for an estimated value of $12.50M.
What is the percentage of profitable transactions made by ARCH Venture Fund XIII, L.P.?
The percentage of profitable transactions made by ARCH Venture Fund XIII, L.P. is ―.
What is the average return per transaction made by ARCH Venture Fund XIII, L.P.?
The average return per transaction made by ARCH Venture Fund XIII, L.P. is ―.
What stocks does ARCH Venture Fund XIII, L.P. hold?
ARCH Venture Fund XIII, L.P. holds: LYEL stocks.
What was ARCH Venture Fund XIII, L.P.’s latest transaction?
ARCH Venture Fund XIII, L.P. latest transaction was an Informative Buy of $12.50M.
What was ARCH Venture Fund XIII, L.P.'s most profitable transaction?
ARCH Venture Fund XIII, L.P.’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is ARCH Venture Fund XIII, L.P.'s role in Lyell Immunopharma?
ARCH Venture Fund XIII, L.P.'s role in Lyell Immunopharma is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.